longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Beilu Pharma

300016

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 32.57, below the reasonable range, cheaper than 99.61% of the time in the past 1 years, and the industry ranks 80/221, the industry Median 23.00.

32.57xP/E
¥7.98Stock price
¥0.25Earnings per share
32.57xP/E
Stock price¥7.98Earnings per share¥0.25

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
138.05x
Typical range
38.65x–172.39x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.00x
010203040

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.00x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600276SHHengrui Pharma
36.65x17.99%¥283.21B
600436SHZZPZH
39.92x1.29%¥72.24B
002422SZKELUN PHARMA
34.22x15.33%¥62.60B
600085SHTRT
33.08x4.81%¥32.09B
600329SHDRTG
31.35x51.62%¥26.59B
000739SZAPELOA
29.90x23.79%¥25.42B
600521SHHuahaipharm
36.65x305.56%¥23.01B
600664SHHPGC
34.37x71.43%¥17.60B
603456SHJiuzhou Pharma
21.59x12.93%¥12.78B
603707SHNKF
24.86x11.11%¥12.00B
002019SZYifan Pharmaceutical
36.89x12.12%¥11.19B
600420SHSHYNDEC
20.40x--¥11.12B
600572SHCONBA
21.49x--¥10.71B
300357SZWolwo Pharma
23.81x18.88%¥9.94B
002626SZKingdomway
37.02x56.36%¥9.72B
688076SHSinopep
37.40x91.51%¥8.88B
002332SZXJZY
21.89x5.56%¥8.45B
002550SZQianhong Bio-pharma
27.51x--¥8.08B
300119SZRINGPU
23.00x4.65%¥8.01B
688513SHEASTON BIOPHARMACEUTICALS
28.43x0.00%¥7.88B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.